Q&A: Takeda’s Elena Koundourakis Talks Orexin Program Ahead of Expected Readout

Speaking to BioSpace in San Francisco, Elena Koundourakis, the head of the orexin franchise at Takeda Pharmaceuticals, gave a preview of what is ahead for its aims to treat narcolepsy.